Systemic metabolic markers and myocardial glucose uptake in type 2 diabetic and coronary artery disease patients

This paper studies the effects of rosiglitazone treatment on circulating low-molecular-weight metabolites and lipoprotein subclasses and lipids that are associated with type 2 diabetes.

Stay in the know

Our latest health headlines delivered to your inbox.